Drug
Shr 3167
Shr 3167: highest development phase Phase 3, developed by Jiangsu Hengrui Medicine. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| SHR-3167 Injection NCT07920939 | Phase 3 | Type 2 Diabetes |
| SHR-3167 NCT07913061 | Phase 3 | Diabetes Mellitus, Type 2 |
| SHR-3167 Injection NCT07472725 | Phase 2 | Diabetes Mellitus, Type 2 |
Latest
Follow Shr 3167 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.